Supplement analysis backed by scientific evidence · PT

← All supplements
Limited evidenceWomen's health

Red Clover

Red clover isoflavones produce at best a small reduction in hot flushes — around one to two flushes per day more than placebo in pooled trials — which reviewers have questioned as falling short of clinical meaningfulness. Other claims (bone, cardiovascular) are weaker still.

What the science says

  • Reduces menopausal hot flushes Limited evidence

    A 2021 systematic review and meta-analysis of randomized controlled trials specifically evaluated whether red clover extract's effect on hot flushes is clinically meaningful, and found the reduction in daily flush frequency versus placebo — on the order of one to two flushes per day — sits at the edge of what women would notice, with substantial heterogeneity across trials. Doses were typically 40-80 mg isoflavones/day for 12-16 weeks. Placebo response in hot flush trials is large (often 30-50%), which further shrinks the real-world gain.

  • Improves blood lipids Limited evidence

    A randomized, double-blind, placebo-controlled trial of formononetin-enriched red clover isoflavones in postmenopausal women reported a statistically significant fall in LDL cholesterol versus placebo. This is a single trial with a specific enriched preparation, and it has not been replicated with standard commercial products; do not expect a red clover capsule to substitute for a statin or for dietary change.

  • Preserves bone mineral density Limited evidence

    Bone endpoints have been studied mostly in small trials, often as combination products (isoflavones plus probiotics or calcium), making the red clover contribution impossible to isolate. Effects on bone turnover markers have been inconsistent, and no trial is powered for fracture outcomes.

  • Improves skin, hair or libido Limited evidence

    These are marketing extrapolations from the isoflavone-as-phytoestrogen premise rather than findings. Trials in menopausal sexual function using phytoestrogens broadly are small, heterogeneous, and confounded by concurrent symptom relief; there is no adequate red-clover-specific evidence.

Dosage & safety

Studied doseTrials used standardized extracts delivering 40-80 mg total isoflavones/day (biochanin A, formononetin, genistein, daidzein), taken daily for 12 weeks to 12 months. There is no evidence that going above 80 mg/day adds benefit.
SafetyUsually well tolerated; nausea, headache, rash and breast tenderness are the common complaints. Red clover is a phytoestrogen, so avoid it in estrogen-receptor-positive breast cancer, endometrial cancer, or while taking tamoxifen or aromatase inhibitors without oncology sign-off — isoflavones can theoretically compete at the receptor. The plant contains coumarins; concentrated preparations and fermented material may add bleeding risk with warfarin, DOACs, or antiplatelet drugs, so stop 2 weeks before surgery. Avoid in pregnancy and breastfeeding. Endometrial safety data extend to about 12 months only; longer use has not been studied.

Scientific references

Where to buy

Vitacost, Red Clover Blossom, 120 Capsules (375 mg per Capsule)

View on iHerb

Referral link — this site may earn a commission on purchases.

Related in Women's health